Category Archives: Vioxx

Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Google Searches Could Help FDA Identify Drug Side Effects

Google Searches Could Help FDA Identify Drug Side Effects

The Food and Drug Administration (FDA) has asked for Google’s help in identifying previously unknown side effects of medications. Last month, in a conference call, FDA officials spoke with a senior Google researcher who co-authored a 2013 paper about using search query … Continue reading

Posted in Health Concerns, Pharmaceuticals, Vioxx | Tagged , , , , |

Mis-marketing of Drugs Cost Billions, Endangers Health

Mis-marketing of Drugs Cost Billions, Endangers Health

A new report from the Center for Economic and Policy Research (CEPR) describes the high costs associated with the mis-marketing of prescription drugs, both in dollars and in health consequences. Spending on prescription drugs has consistently been the fastest growing … Continue reading

Posted in Avandia, Defective Products, Health Concerns, Pharmaceuticals, Vioxx | Tagged , , , , |

Vioxx Off-Label Marketing To Cost Merck $321 Million

Vioxx off-label marketing activities are going to cost Merck & Co. a whopping $321 million in criminal fines. The U.S. Food & Drug Administration (FDA) approved Vioxx (rofecoxib), a painkiller, for three indications in May 1999. Merck has pleaded guilty … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx | Tagged |

Vioxx Caused Complications Months After Patients Dropped It

< "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (Generic: rofecoxib), Merck’s blockbuster painkiller, might be responsible for blood clots in patients after they stopped taking it, write U.S. researchers, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a bestseller for Merck, with annual … Continue reading

Posted in Pharmaceuticals, Vioxx |

Supreme Court Gives Go Ahead to Vioxx Investor Lawsuit

Yesterday, the U.S. Supreme Court gave the go-ahead for a securities fraud lawsuit against pharmaceutical giant, Merck & Co Inc., over its disclosures to investors about < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a … Continue reading

Posted in Class Action Lawsuits, Health Concerns, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Settlement Almost Wrapped Up

Merck & Co. has made a final $4.1 billion payment to its < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx settlement fund. According to an Associated Press report, final payouts to former Vioxx users or their survivors should be made by the end of June. Vioxx … Continue reading

Posted in Pharmaceuticals, Vioxx |

Doctor Accused of Falsifying Drug Studies Pleads Guilty

Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health care fraud. As we’ve reported previously, Reuben was charged in federal court last month with … Continue reading

Posted in Pharmaceuticals, Vioxx |

Vioxx Scandal Didn’t Lead To Changes At FDA

The < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx scandal, and the Food & Drug Administration’s (FDA) role in it, has not brought about much change at the agency, according to a new government report. Vioxx was approved for use in 1999, and quickly became a … Continue reading

Posted in Pharmaceuticals, Vioxx |

Vioxx Shareholder Lawsuit Before US Supreme Court

Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx |

Vioxx Dangers Should Have Been Known Years Before Recall

We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have … Continue reading

Posted in Pharmaceuticals, Vioxx |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.